Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | KOD |
---|---|---|
09:32 ET | 669 | 2.47 |
09:34 ET | 1308 | 2.4 |
09:36 ET | 1560 | 2.33 |
09:38 ET | 4600 | 2.45 |
09:54 ET | 100 | 2.4 |
09:59 ET | 1000 | 2.4328 |
10:01 ET | 2540 | 2.39 |
10:03 ET | 469 | 2.39 |
10:06 ET | 173 | 2.405 |
10:14 ET | 2112 | 2.398 |
10:15 ET | 2810 | 2.39 |
10:19 ET | 155 | 2.3708 |
10:21 ET | 200 | 2.38 |
10:24 ET | 900 | 2.38 |
10:26 ET | 700 | 2.39 |
10:33 ET | 11801 | 2.43 |
10:35 ET | 100 | 2.43 |
10:37 ET | 1073 | 2.44 |
10:42 ET | 600 | 2.422 |
10:53 ET | 109 | 2.42 |
11:08 ET | 1000 | 2.4214 |
11:18 ET | 500 | 2.4325 |
11:24 ET | 245 | 2.4481 |
11:26 ET | 492 | 2.4316 |
11:31 ET | 430 | 2.45 |
11:36 ET | 353 | 2.45 |
11:38 ET | 100 | 2.465 |
11:40 ET | 1476 | 2.45 |
11:45 ET | 1815 | 2.4685 |
11:49 ET | 700 | 2.46 |
11:51 ET | 105 | 2.47 |
11:54 ET | 100 | 2.46 |
11:56 ET | 1050 | 2.48 |
11:58 ET | 5020 | 2.51 |
12:02 ET | 1284 | 2.5 |
12:09 ET | 100 | 2.5 |
12:16 ET | 100 | 2.5 |
12:18 ET | 1553 | 2.5 |
12:27 ET | 100 | 2.49 |
12:30 ET | 330 | 2.49 |
12:32 ET | 100 | 2.505 |
12:36 ET | 875 | 2.51 |
12:41 ET | 105 | 2.51 |
12:43 ET | 100 | 2.51 |
12:48 ET | 2508 | 2.51 |
12:57 ET | 977 | 2.49 |
01:01 ET | 100 | 2.49 |
01:03 ET | 245 | 2.5 |
01:08 ET | 100 | 2.49 |
01:12 ET | 172 | 2.49 |
01:14 ET | 1469 | 2.49 |
01:33 ET | 1942 | 2.49 |
01:35 ET | 2200 | 2.51 |
01:44 ET | 3358 | 2.495 |
01:48 ET | 1700 | 2.52 |
01:50 ET | 2726 | 2.52 |
01:51 ET | 300 | 2.5101 |
01:53 ET | 100 | 2.52 |
01:57 ET | 100 | 2.52 |
02:20 ET | 298 | 2.53 |
02:22 ET | 100 | 2.525 |
02:24 ET | 100 | 2.53 |
02:26 ET | 1636 | 2.53 |
02:31 ET | 900 | 2.54 |
02:33 ET | 205 | 2.545 |
02:36 ET | 200 | 2.545 |
02:40 ET | 1355 | 2.545 |
02:42 ET | 5854 | 2.57 |
02:44 ET | 104 | 2.57 |
02:45 ET | 1710 | 2.565 |
02:47 ET | 9836 | 2.59 |
02:49 ET | 1209 | 2.6 |
02:51 ET | 3058 | 2.58 |
02:56 ET | 200 | 2.58 |
02:58 ET | 952 | 2.58 |
03:00 ET | 100 | 2.58 |
03:05 ET | 4970 | 2.58 |
03:09 ET | 800 | 2.5803 |
03:14 ET | 1507 | 2.575 |
03:21 ET | 407 | 2.58 |
03:23 ET | 1200 | 2.58 |
03:25 ET | 1900 | 2.585 |
03:36 ET | 1212 | 2.59 |
03:39 ET | 3626 | 2.59 |
03:41 ET | 4178 | 2.58 |
03:43 ET | 300 | 2.58 |
03:45 ET | 600 | 2.585 |
03:48 ET | 200 | 2.59 |
03:50 ET | 100 | 2.59 |
03:52 ET | 2900 | 2.6 |
03:54 ET | 5620 | 2.6 |
03:56 ET | 3350 | 2.605 |
03:57 ET | 1195 | 2.61 |
03:59 ET | 32341 | 2.61 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Kodiak Sciences Inc | 137.3M | -0.7x | --- |
Immunic Inc | 140.5M | -1.0x | --- |
Outlook Therapeutics Inc | 132.0M | -0.7x | --- |
Invivyd Inc | 130.2M | -0.6x | --- |
aTyr Pharma Inc | 131.9M | -1.9x | --- |
Acumen Pharmaceuticals Inc | 146.6M | -2.2x | --- |
Kodiak Sciences Inc. is a biopharmaceutical company. The Company has developed a new technology platform, the Antibody Biopolymer Conjugate (ABC) Platform, for retinal medicines. Its ABC Platform uses molecular engineering to merge the fields of protein-based and chemistry-based therapies. Its lead investigational medicine, tarcocimab, is a novel anti-vascular endothelial growth factor (anti-VEGF) antibody biopolymer conjugate under development for the treatment of high prevalence retinal vascular diseases, including diabetic retinopathy, the cause of blindness in working-age patients in the developed world, and wet age-related macular degeneration, the cause of blindness in elderly patients. Its second investigational medicine, KSI-501, is a bispecific antibody biopolymer conjugate targeting the pro-inflammatory cytokine interleukin-6 (IL-6) and VEGF. It is also developing a third investigational medicine, KSI-101, an unconjugated bispecific protein targeting IL-6 and VEGF.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $137.3M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 52.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.34 |
EPS | $-3.77 |
Book Value | $5.06 |
P/E Ratio | -0.7x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.